Abstract
Publication details
- DOI
- 10.4103/0974-620x.60023
- Journal
- Oman Journal of Ophthalmology, 3(1), 38-40
- Publisher
- Medknow Publications
- Open access
- Gold open access
Cite this article
APA 7
Nema, N., & Ip, M. S. (2010). Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis. Oman Journal of Ophthalmology, 3(1), 38-40. https://doi.org/10.4103/0974-620x.60023
MLA 9
Nema, Nitin, and Michael S Ip. "Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis." Oman Journal of Ophthalmology, vol. 3, no. 1, 2010, pp. 38-40. https://doi.org/10.4103/0974-620x.60023.
Chicago (author–date)
Nema, Nitin, and Michael S Ip. 2010. "Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis." Oman Journal of Ophthalmology 3 (1): 38-40. https://doi.org/10.4103/0974-620x.60023.
Harvard
Nema, N. and Ip, M. S. (2010) 'Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis', Oman Journal of Ophthalmology, 3(1), pp. 38-40. doi:10.4103/0974-620x.60023.
Vancouver
Nema N, Ip MS. Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis. Oman Journal of Ophthalmology. 2010;3(1):38-40. doi:10.4103/0974-620x.60023
IEEE
N. Nema, and M. S. Ip, "Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis," Oman Journal of Ophthalmology, vol. 3, no. 1, pp. 38-40, 2010, doi: 10.4103/0974-620x.60023.